Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.51USD
18 Apr 2019
Change (% chg)

$0.03 (+2.03%)
Prev Close
$1.48
Open
$1.50
Day's High
$1.51
Day's Low
$1.50
Volume
212
Avg. Vol
2,532
52-wk High
$3.15
52-wk Low
$1.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.24 -0.038
Sep '18 0.28 -0.098
Jun '18 0.39 -0.075
Mar '18 0.23 -0.109
FY 2017 Dec '17 0.87 -0.104
Sep '17 0.30 -0.112
Jun '17 0.21 -0.500
Mar '17 0.57 -0.151
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 103.27 57.80
P/E High - Last 5 Yrs. 9.46 164.39 56.06
P/E Low - Last 5 Yrs. 9.46 52.66 28.61
Beta 0.83 1.12 0.93
Price to Sales (TTM) 14.99 45.66 9.15
Price to Book (MRQ) -- 12.64 4.46
Price to Tangible Book (MRQ) -- 17.91 7.62
Price to Cash Flow (TTM) -- 68.67 40.14
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.54
Dividend Yield - 5 Year Avg -- 0.05 0.70
Dividend 5 Year Growth Rate -- 0.75 2.99
Payout Ratio(TTM) -- 8.79 21.84

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -72.92 25.01 9.34
Sales (TTM) vs TTM 1 Yr. Ago -41.58 70.93 8.40
Sales - 5 Yr. Growth Rate -33.09 33.13 10.97
EPS (MRQ) vs Qtr. 1 Yr. Ago 63.11 -92.89 108.58
EPS (TTM) vs TTM 1 Yr. Ago 63.11 -- --
EPS - 5 Yr. Growth Rate -- 21.70 6.90
Capital Spending - 5 Yr. Growth Rate -27.53 25.75 7.55

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.72 2.67
Current Ratio (MRQ) 4.91 3.61 3.64
LT Debt to Equity (MRQ) -- 7.28 13.32
Total Debt to Equity (MRQ) -- 20.11 17.00
Interest Coverage (TTM) -1.32 8.38 27.17

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.39 50.39
Gross Margin - 5 Yr. Avg. -- 59.67 50.83
EBITD Margin (TTM) -420.12 -- --
EBITD - 5 Yr. Avg -319.06 -14.57 15.70
Operating Margin (TTM) -421.71 -117.15 3.07
Operating Margin - 5 Yr. Avg. -213.31 -30.23 11.04
Pre-Tax Margin (TTM) -325.73 -117.60 2.34
Pre-Tax Margin - 5 Yr. Avg. -223.97 -32.86 16.58
Net Profit Margin (TTM) -325.73 -123.95 -1.58
Net Profit Margin - 5 Yr. Avg. -223.97 -37.92 11.58
Effective Tax Rate (TTM) -- 19.85 22.81
Effective Tax Rate - 5 Yr. Avg. -- 19.62 23.89

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 8,759,241 777,453,280
Net Income/Employee (TTM) -- 2,000,017 89,549,931
Receivable Turnover (TTM) 2.82 2.40 5.24
Inventory Turnover (TTM) -- 2.31 3.67
Asset Turnover (TTM) 0.16 0.32 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.35 6.23 9.57
Return on Assets - 5 Yr. Avg. -44.24 6.13 10.52
Return on Investment (TTM) -970.88 7.81 11.82
Return on Investment - 5 Yr. Avg. -165.70 8.02 13.42
Return on Equity (TTM) -966.05 7.87 12.64
Return on Equity - 5 Yr. Avg. -215.59 9.08 14.89
  1 Year 3 Year 5 Year
Sales % -41.58 -25.10 -33.09
EPS (TTM) % 63.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cleveland Biolabs Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.41%
# of Holders: 22
Total Shares Held: 610,698
3 Mo. Net Change: 453
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.